CNTX Context Therapeutics Inc.

NASDAQ

$0.35

Context Therapeutics Inc. (CNTX) Earnings News

Earnings press releases, previews and reviews for Context Therapeutics Inc. (CNTX), newest first.

Wednesday August 5, 2026 4:14 PM ET

Context Therapeutics Reports Second Quarter 2026 Operating and Pipeline Progress

Wednesday May 6, 2026 4:18 PM ET

Context Therapeutics Reports First Quarter 2026 Operating and Financial Results